Now published: Rationale, design, and baseline characteristics of the BETonMACE trial

No such message found

...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

Reply New Message

Prev Message Back To Forum Threaded View Next Message

BearDownAZ

Rank: President [?]

Points: 25003 [?]

Votes: 68 Score: 4.5 [?]

Your Vote:

Please Log In to Vote

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

Now published: Rationale, design, and baseline characteristics of the BETonMACE trial

posted on Aug 10, 2019 12:14PM

Looks like the BETonMACE rationale, design and baseline characteristics paper was published yesterday! Unfortunately, I don't have access to the full text.

Just saw this on Twitter: https://twitter.com/novitskiynic/status/1160084484198457344?s=20

Effect of selective BET protein inhibitor apabetalone on cardiovascular outcomes in patients with acute coronary syndrome and diabetes: Rationale, design, and baseline characteristics of the BETonMACE trial

https://www.sciencedirect.com/science/article/abs/pii/S0002870319301978

4 Recommendations

Reply New Message

Prev Message Back To Forum Threaded View Next Message

Please to post a reply